Bioengineered niches that recreate physiological extracellular matrix organisation to support long-term haematopoietic stem cells.
Hematopoietic Stem Cells
/ metabolism
Animals
Nestin
/ metabolism
Extracellular Matrix
/ metabolism
Hypoxia-Inducible Factor 1, alpha Subunit
/ metabolism
Mice
Stem Cell Niche
Hydrogels
/ chemistry
Bioengineering
/ methods
Humans
Mesenchymal Stem Cells
/ metabolism
Hematopoietic Stem Cell Transplantation
Antigens, CD34
/ metabolism
Collagen Type I
/ metabolism
Cell Differentiation
Mice, Inbred C57BL
Journal
Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555
Informations de publication
Date de publication:
10 Jul 2024
10 Jul 2024
Historique:
received:
09
08
2022
accepted:
27
06
2024
medline:
11
7
2024
pubmed:
11
7
2024
entrez:
10
7
2024
Statut:
epublish
Résumé
Long-term reconstituting haematopoietic stem cells (LT-HSCs) are used to treat blood disorders via stem cell transplantation. The very low abundance of LT-HSCs and their rapid differentiation during in vitro culture hinders their clinical utility. Previous developments using stromal feeder layers, defined media cocktails, and bioengineering have enabled HSC expansion in culture, but of mostly short-term HSCs and progenitor populations at the expense of naive LT-HSCs. Here, we report the creation of a bioengineered LT-HSC maintenance niche that recreates physiological extracellular matrix organisation, using soft collagen type-I hydrogels to drive nestin expression in perivascular stromal cells (PerSCs). We demonstrate that nestin, which is expressed by HSC-supportive bone marrow stromal cells, is cytoprotective and, via regulation of metabolism, is important for HIF-1α expression in PerSCs. When CD34
Identifiants
pubmed: 38987295
doi: 10.1038/s41467-024-50054-0
pii: 10.1038/s41467-024-50054-0
doi:
Substances chimiques
Nestin
0
Hypoxia-Inducible Factor 1, alpha Subunit
0
Hydrogels
0
Antigens, CD34
0
Collagen Type I
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5791Subventions
Organisme : RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)
ID : BB/N018419/1
Organisme : RCUK | Engineering and Physical Sciences Research Council (EPSRC)
ID : EP/P001114/1
Organisme : RCUK | Medical Research Council (MRC)
ID : MR/R005567/1
Informations de copyright
© 2024. The Author(s).
Références
Burns, R., Leal, J., Sullivan, R. & Luengo-Fernandez, R. Economic burden of malignant blood disorders across Europe: a population-based cost analysis. Lancet Haematol. 3, e362–e370 (2016).
pubmed: 27476787
doi: 10.1016/S2352-3026(16)30062-X
Granot, N. & Storb, R. History of hematopoietic cell transplantation: challenges and progress. Haematologica 105, 2716–2729 (2020).
pubmed: 33054108
pmcid: 7716373
doi: 10.3324/haematol.2019.245688
State of the Registry 2020–2021. In: Anthony Nolan NHS Stem Cell Registry Annual Review 1–10 https://www.anthonynolan.org/sites/default/files/2022-06/State%20of%20The%20Registry%202020-2021.pdf (2022).
Zon, L. I. Intrinsic and extrinsic control of haematopoietic stem-cell self-renewal. Nature 453, 306–313 (2008).
pubmed: 18480811
doi: 10.1038/nature07038
Yang, L. et al. Identification of Lin-Sca1+kit+CD34 +Flt3- short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 105, 2717–2723 (2005).
pubmed: 15572596
doi: 10.1182/blood-2004-06-2159
Dexter, T., Moore, M. A. & Sheridan, A. P. Maintenance of hemopoietic stem cells and production of differentiated progeny in allogeneic and semiallogeneic bone marrow chimeras in vitro. J. Exp. Med. 145, 1612–1616 (1977).
pubmed: 325171
doi: 10.1084/jem.145.6.1612
Nakauchi, H., Sudo, K. & Hideo, E. M. A. Quantitative assessment of the stem cell self-renewal capacity. Ann. N. Y. Acad. Sci. 938, 18–25 (2001).
pubmed: 11458506
doi: 10.1111/j.1749-6632.2001.tb03570.x
Li, J. et al. Development and clinical advancement of small molecules for ex vivo expansion of hematopoietic stem cell. Acta Pharm. Sin. B 12, 2808–2831 (2021).
pubmed: 35755294
pmcid: 9214065
doi: 10.1016/j.apsb.2021.12.006
Fares, I. et al. EPCR expression marks UM171-expanded CD34+ cord blood stem cells. Blood 129, 3344–3351 (2017).
pubmed: 28408459
doi: 10.1182/blood-2016-11-750729
Wagner, J. E. et al. Phase I/II trial of stemregenin-1 expanded umbilical cord blood hematopoietic stem cells supports testing as a stand-alone graft. Cell Stem Cell 18, 144–155 (2016).
pubmed: 26669897
doi: 10.1016/j.stem.2015.10.004
Pinho, S. & Frenette, P. S. Haematopoietic stem cell activity and interactions with the niche. Nat. Rev. Mol. Cell Biol. https://doi.org/10.1038/s41580-019-0103-9 (2019).
Méndez-Ferrer, S. et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466, 829–834 (2010).
pubmed: 20703299
pmcid: 3146551
doi: 10.1038/nature09262
Kunisaki, Y. et al. Arteriolar niches maintain haematopoietic stem cell quiescence. Nature 502, 637–643 (2013).
pubmed: 24107994
pmcid: 3821873
doi: 10.1038/nature12612
Ding, L. & Morrison, S. J. Haematopoietic stem cells and early lymphoid progenitors occupy distinct bone marrow niches. Nature 495, 231–235 (2013).
pubmed: 23434755
pmcid: 3600153
doi: 10.1038/nature11885
Sacchetti, B. et al. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131, 324–336 (2007).
pubmed: 17956733
doi: 10.1016/j.cell.2007.08.025
Crisan, M. et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301–313 (2008).
pubmed: 18786417
doi: 10.1016/j.stem.2008.07.003
Sugiyama, T., Kohara, H., Noda, M. & Nagasawa, T. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25, 977–988 (2006).
pubmed: 17174120
doi: 10.1016/j.immuni.2006.10.016
Pinho, S. et al. PDGFR A and CD51 mark human stem cells capable of hematopoietic progenitor cell expansion. J. Exp. Med. 210, 1351–1367 (2013).
pubmed: 23776077
pmcid: 3698522
doi: 10.1084/jem.20122252
Engler, A. J., Sen, S., Sweeney, H. L. & Discher, D. E. Matrix elasticity directs stem cell lineage specification. Cell 126, 677–689 (2006).
pubmed: 16923388
doi: 10.1016/j.cell.2006.06.044
Chen, X. et al. Mechanical heterogeneity in the bone microenvironment as characterized by atomic force microscopy. Biophys. J. 119, 502–513 (2020).
pubmed: 32668233
pmcid: 7401034
doi: 10.1016/j.bpj.2020.06.026
Calvi, L. M. et al. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425, 841–846 (2003).
pubmed: 14574413
doi: 10.1038/nature02040
Shen, B. et al. A mechanosensitive peri-arteriolar niche for osteogenesis and lymphopoiesis. Nature 591, 438–444 (2021).
Salmerón-Sánchez, M. & Dalby, M. J. Synergistic growth factor microenvironments. Chem. Commun. 52, 13327–13336 (2016).
doi: 10.1039/C6CC06888J
Spencer, J. A. et al. Direct measurement of local oxygen concentration in the bone marrow of live animals. Nature 508, 269–273 (2014).
pubmed: 24590072
pmcid: 3984353
doi: 10.1038/nature13034
Estrada, J. C. et al. Culture of human mesenchymal stem cells at low oxygen tension improves growth and genetic stability by activating glycolysis. Cell Death Differ. 19, 743–755 (2012).
pubmed: 22139129
doi: 10.1038/cdd.2011.172
Guarnerio, J. et al. Bone marrow endosteal mesenchymal progenitors depend on HIF factors for maintenance and regulation of hematopoiesis. Stem Cell Rep. 2, 794–809 (2014).
doi: 10.1016/j.stemcr.2014.04.002
Nakahara, F. et al. Engineering a haematopoietic stem cell niche by revitalizing mesenchymal stromal cells. Nat. Cell Biol. 21, 560–567 (2019).
pubmed: 30988422
pmcid: 6499646
doi: 10.1038/s41556-019-0308-3
Leisten, I. et al. 3D co-culture of hematopoietic stem and progenitor cells and mesenchymal stem cells in collagen scaffolds as a model of the hematopoietic niche. Biomaterials 33, 1736–1747 (2012).
pubmed: 22136713
doi: 10.1016/j.biomaterials.2011.11.034
Gilchrist, A. E. & Harley, B. A. C. Connecting secretome to hematopoietic stem cell phenotype shifts in an engineered bone marrow niche. Integr. Biol. 12, 175–187 (2020).
doi: 10.1093/intbio/zyaa013
Bourgine, P. E. et al. In vitro biomimetic engineering of a human hematopoietic niche with functional properties. Proc. Natl. Acad. Sci. 115, E5688–E5695 (2018).
pubmed: 29866839
pmcid: 6016789
doi: 10.1073/pnas.1805440115
Rödling, L. et al. 3D models of the hematopoietic stem cell niche under steady-state and active conditions. Sci. Rep. 1–15 https://doi.org/10.1038/s41598-017-04808-0 (2017).
Chou, D. B. et al. On-chip recapitulation of clinical bone marrow toxicities and patient-specific pathophysiology. Nat. Biomed. Eng. 4, 394–406 (2020).
Doulatov, S., Notta, F., Laurenti, E. & Dick, J. E. Hematopoiesis: a human perspective. Cell Stem Cell 10, 120–136 (2012).
pubmed: 22305562
doi: 10.1016/j.stem.2012.01.006
Klamer, S. & Voermans, C. The role of novel and known extracellular matrix and adhesion molecules in the homeostatic and regenerative bone marrow microenvironment. Cell Adh. Migr. 8, 563–577 (2014).
pubmed: 25482635
pmcid: 4594522
doi: 10.4161/19336918.2014.968501
Llopis-hernández, V. et al. Material-driven fibronectin assembly for high-efficiency presentation of growth factors. Sci. Adv. 1–11 https://doi.org/10.1126/sciadv.1600188 (2016).
Cheng, Z. A. et al. Nanoscale coatings for ultralow dose BMP-2-driven regeneration of critical-sized bone defects. Adv. Sci. 6, 1800361 (2018).
doi: 10.1002/advs.201800361
Itkin, T. et al. Distinct bone marrow blood vessels differentially regulate haematopoiesis. Nature 1–19 https://doi.org/10.1038/nature17624 (2016).
Asada, N. et al. Differential cytokine contributions of perivascular haematopoietic stem cell niches. https://doi.org/10.1038/ncb3475 (2017).
Nilsson, S. K. et al. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ. J. Histochem. Cytochem. 46, 371–377 (1998).
pubmed: 9487119
doi: 10.1177/002215549804600311
Choi, J. S. & Harley, B. A. C. Marrow-inspired matrix cues rapidly affect early fate decisions of hematopoietic stem and progenitor cells. Sci. Adv. 3, e1600455 (2017).
pubmed: 28070554
pmcid: 5218514
doi: 10.1126/sciadv.1600455
Früh, S. M., Schoen, I., Ries, J. & Vogel, V. Molecular architecture of native fibronectin fibrils. Nat. Commun. 6, 7275 (2015).
pubmed: 26041410
doi: 10.1038/ncomms8275
Klotzsch, E. et al. Fibronectin forms the most extensible biological fibers displaying switchable force-exposed cryptic binding sites. Proc. Natl. Acad. Sci. USA 106, 18267–18272 (2009).
pubmed: 19826086
pmcid: 2761242
doi: 10.1073/pnas.0907518106
Bieniek, M., Llopis-Hernandez, V., Douglas, K., Salmeron-Sanchez, M. & Lorenz, C. Minor chemistry changes alter surface hydration to control fibronectin adsorption and assembly into nanofibrils. Adv. Theory Simul. 1900169, 1–13 (2019).
Martino, M. M. & Hubbell, J. A. The 12th-14th type III repeats of fibronectin function as a highly promiscuous growth factor-binding domain. FASEB J. 24, 4711–4721 (2010).
pubmed: 20671107
Park, D. et al. Nestin is required for the proper self-renewal of neural stem cells. Stem Cells 28, 2162–2171 (2010).
pubmed: 20963821
doi: 10.1002/stem.541
Coutu, D. L., Kokkaliaris, K. D., Kunz, L. & Schroeder, T. Three-dimensional map of nonhematopoietic bone and bone-marrow cells and molecules. Nat. Biotechnol. 35, 1202–1210 (2017).
pubmed: 29131149
doi: 10.1038/nbt.4006
Le Blanc, K. & Mougiakakos, D. Multipotent mesenchymal stromal cells and the innate immune system. Nat. Rev. Immunol. 12, 383–396 (2012).
pubmed: 22531326
doi: 10.1038/nri3209
Dorronsoro, A. et al. Intracellular role of IL-6 in mesenchymal stromal cell immunosuppression and proliferation. Sci. Rep. 10, 1–12 (2020).
doi: 10.1038/s41598-020-78864-4
Haghighitalab, A. et al. Investigating the effects of IDO1, PTGS2, and TGF-β1 overexpression on immunomodulatory properties of hTERT-MSCs and their extracellular vesicles. Sci. Rep. 11, 1–19 (2021).
doi: 10.1038/s41598-021-87153-7
He, Y. et al. Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia. Br. J. Haematol. 180, 395–411 (2018).
pubmed: 29327472
doi: 10.1111/bjh.15034
Shen, S. P. et al. EphA2 is a biomarker of hMSCs derived from human placenta and umbilical cord. Taiwan. J. Obstet. Gynecol. 54, 749–756 (2015).
pubmed: 26700997
doi: 10.1016/j.tjog.2015.10.012
Weidemann, A. & Johnson, R. S. Biology of HIF-1 a. Cell Death Differ. 15, 621–627 (2008).
pubmed: 18259201
doi: 10.1038/cdd.2008.12
Pattappa, G., Heywood, H. K., de Bruijn, J. D. & Lee, D. A. The metabolism of human mesenchymal stem cells during proliferation and differentiation. J. Cell. Physiol. 226, 2562–2570 (2011).
pubmed: 21792913
doi: 10.1002/jcp.22605
Vander Heiden, M. G., Cantley, L. C. & Thompson, C. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029–1033 (2009).
doi: 10.1126/science.1160809
Sahlgren, C. M. et al. Cdk5 regulates the organization of Nestin and its association with p35. Mol. Cell. Biol. 23, 5090–5106 (2003).
pubmed: 12832492
pmcid: 162223
doi: 10.1128/MCB.23.14.5090-5106.2003
Pallari, H.-M. et al. Nestin as a regulator of Cdk5 in differentiating myoblasts. Mol. Biol. Cell 22, 1539–1549 (2011).
pubmed: 21346193
pmcid: 3084676
doi: 10.1091/mbc.e10-07-0568
Sahlgren, C. M. et al. A nestin scaffold links Cdk5/p35 signaling to oxidant-induced cell death. EMBO J. 25, 4808–4819 (2006).
pubmed: 17036052
pmcid: 1618100
doi: 10.1038/sj.emboj.7601366
Galleu, A. et al. Apoptosis in mesenchymal stromal cells induces in vivo recipient-mediated immunomodulation. Sci. Transl. Med. 9, 1–12 (2017).
doi: 10.1126/scitranslmed.aam7828
Shentu, Y. et al. Nestin promotes peritoneal fibrosis by protecting HIF1-α from proteasomal degradation. Front. Physiol. 11, 1–11 (2020).
doi: 10.3389/fphys.2020.517912
Van Galen, P. et al. Reduced lymphoid lineage priming promotes human hematopoietic stem cell expansion. Cell Stem Cell 14, 94–106 (2014).
pubmed: 24388174
doi: 10.1016/j.stem.2013.11.021
Wu, Y. et al. Highly efficient therapeutic gene editing of human hematopoietic stem cells. Nat. Med. 25, 776–783 (2019).
pubmed: 30911135
pmcid: 6512986
doi: 10.1038/s41591-019-0401-y
Grassinger, J., Haylock, D. N., Williams, B., Olsen, G. H. & Nilsson, S. K. Phenotypically identical hemopoietic stem cells isolated from different regions of bone marrow have different biologic potential. Blood 116, 3185–3196 (2010).
pubmed: 20631378
doi: 10.1182/blood-2009-12-260703
Ross, E. A. et al. Nanotopography reveals metabolites that maintain the immunosuppressive phenotype of mesenchymal stem cells. Nat. Commun. 14, 753 (2023).
pubmed: 36765065
pmcid: 9918539
doi: 10.1038/s41467-023-36293-7
Wilson, A. et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 135, 1118–1129 (2008).
pubmed: 19062086
doi: 10.1016/j.cell.2008.10.048
Crippa, S. et al. Erratum: mesenchymal stromal cells improve the transplantation outcome of CRISPR-Cas9 gene-edited human HSPCs (Molecular Therapy, (S1525001622004993), (10.1016/j.ymthe.2022.08.011)). Mol. Ther. 30, 3333 (2022).
pubmed: 36096132
pmcid: 9552814
doi: 10.1016/j.ymthe.2022.09.005
Chaudhuri, O. et al. Hydrogels with tunable stress relaxation regulate stem cell fate and activity. Nat. Mater. https://doi.org/10.1038/nmat4489 (2015).
Kaufmann, K. B. et al. A latent subset of human hematopoietic stem cells resists regenerative stress to preserve stemness. Nat. Immunol. 22, 723–734 (2021).
pubmed: 33958784
doi: 10.1038/s41590-021-00925-1
García-Prat, L. et al. TFEB-mediated endolysosomal activity controls human hematopoietic stem cell fate. Cell Stem Cell 28, 1838–1850.e10 (2021).
pubmed: 34343492
doi: 10.1016/j.stem.2021.07.003
Napolitano, G. & Ballabio, A. TFEB at a glance. J. Cell Sci. 129, 2475–2481 (2016).
pubmed: 27252382
pmcid: 4958300
doi: 10.1242/jcs.146365
Hsu, C. C. et al. Biophysical regulations of epigenetic state and notch signaling in neural development using microgroove substrates. ACS Appl. Mater. Interfaces https://doi.org/10.1021/acsami.2c01996 (2022).
Tajik, A. et al. Transcription upregulation via force-induced direct stretching of chromatin. Nat. Mater. 15, 1287–1296 (2016).
pubmed: 27548707
pmcid: 5121013
doi: 10.1038/nmat4729
Caiazzo, M. et al. Defined three-dimensional microenvironments boost induction of pluripotency. Nat. Mater. 15, 344–352 (2016).
pubmed: 26752655
doi: 10.1038/nmat4536
Nemec, S. & Kilian, K. A. Materials control of the epigenetics underlying cell plasticity. Nat. Rev. Mater. https://doi.org/10.1038/s41578-020-00238-z (2020).
Takayama, N. et al. The transition from quiescent to activated states in human hematopoietic stem cells is governed by dynamic 3D genome reorganization. Cell Stem Cell 28, 488–501.e10 (2021).
pubmed: 33242413
doi: 10.1016/j.stem.2020.11.001
Nakagawa, R., Soh, J. W. & Michie, A. M. Subversion of protein kinase Cα signaling in hematopoietic progenitor cells results in the generation of a B-cell chronic lymphocytic leukemia-like population in vivo. Cancer Res. 66, 527–534 (2006).
pubmed: 16397269
doi: 10.1158/0008-5472.CAN-05-0841
Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 17, 10 (2011).
doi: 10.14806/ej.17.1.200
Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525–527 (2016).
pubmed: 27043002
doi: 10.1038/nbt.3519
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 1–21 (2014).
doi: 10.1186/s13059-014-0550-8
Westrop, G. D. et al. Metabolomic profiling and stable isotope labelling of Trichomonas vaginalis and Tritrichomonas foetus reveal major differences in amino acid metabolism including the production of 2-hydroxyisocaproic acid, cystathionine and S-methylcysteine. PLoS One 12, e0189072 (2017).
pubmed: 29267346
pmcid: 5739422
doi: 10.1371/journal.pone.0189072
Chokkathukalam, A. et al. MzMatch-ISO: An R tool for the annotation and relative quantification of isotope-labelled mass spectrometry data. Bioinformatics 29, 281–283 (2013).
pubmed: 23162054
doi: 10.1093/bioinformatics/bts674
Miller, P. H. et al. Enhanced normal short-term human myelopoiesis in mice engineered to express human-specific myeloid growth factors. Blood 121, 3–6 (2013).
doi: 10.1182/blood-2012-09-456566
Brinkman, E. K., Chen, T., Amendola, M. & Van Steensel, B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Res. 42, 1–8 (2014).
doi: 10.1093/nar/gku936
Xiao, Y. et al. Current insights into the bone marrow niche: from biology in vivo to bioengineering ex vivo. Biomaterials 286, 121568 (2022).
pubmed: 35580474
doi: 10.1016/j.biomaterials.2022.121568